BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beattie DT, Smith JA. Serotonin pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol. 2008;377:181-203. [PMID: 18398601 DOI: 10.1007/s00210-008-0276-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Fagan-murphy A, Patel BA. Compressed multiwall carbon nanotube composite electrodes provide enhanced electroanalytical performance for determination of serotonin. Electrochimica Acta 2014;138:392-9. [DOI: 10.1016/j.electacta.2014.06.050] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
2 Heithem C, Issaoui G, Khadraoui M, Ladib M, Naija W, Said R. Acute circulatory deficiency due to endocrinal tumoral manipulation: the pinealoblastoma. Pan Afr Med J 2014;18:168. [PMID: 25422686 DOI: 10.11604/pamj.2014.18.168.1983] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Keszthelyi D, Troost FJ, Jonkers DM, van Donkelaar EL, Dekker J, Buurman WA, Masclee AA. Does acute tryptophan depletion affect peripheral serotonin metabolism in the intestine? The American Journal of Clinical Nutrition 2012;95:603-8. [DOI: 10.3945/ajcn.111.028589] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
4 Popoff MR, Poulain B. Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells. Toxins (Basel) 2010;2:683-737. [PMID: 22069606 DOI: 10.3390/toxins2040683] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
5 Emmanuel A. Current management strategies and therapeutic targets in chronic constipation. Therap Adv Gastroenterol. 2011;4:37-48. [PMID: 21317993 DOI: 10.1177/1756283X10384173] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Javid FA, Afshin-Javid S, Horn CC. Further investigation of the effects of 5-hydroxytryptamine, 8-OH-DPAT and DOI to mediate contraction and relaxation responses in the intestine and emesis in Suncus murinus. Eur J Pharmacol 2018;821:79-87. [PMID: 29277716 DOI: 10.1016/j.ejphar.2017.12.051] [Reference Citation Analysis]
7 Kim H, Kim HJ, Yang D, Jung MH, Kim BJ. Depolarizing Effects of Daikenchuto on Interstitial Cells of Cajal from Mouse Small Intestine. Pharmacogn Mag 2017;13:141-7. [PMID: 28216898 DOI: 10.4103/0973-1296.196312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Iwasaki M, Akiba Y, Kaunitz JD. Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases. Curr Gastroenterol Rep 2019;21:35. [PMID: 31289927 DOI: 10.1007/s11894-019-0702-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
9 Beattie DT, Armstrong SR, Vickery RG, Tsuruda PR, Campbell CB, Richardson C, McCullough JL, Daniels O, Kersey K, Li YP, Kim KH. The Pharmacology of TD-8954, a Potent and Selective 5-HT(4) Receptor Agonist with Gastrointestinal Prokinetic Properties. Front Pharmacol 2011;2:25. [PMID: 21687517 DOI: 10.3389/fphar.2011.00025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
10 Roberts AJ, Hedlund PB. The 5-HT(7) receptor in learning and memory. Hippocampus 2012;22:762-71. [PMID: 21484935 DOI: 10.1002/hipo.20938] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 7.5] [Reference Citation Analysis]
11 mitchell NA, pepperell E, ociepka S, brown JD, witherington J, tuladhar B, sanger GJ, lee K, cellek S. 5-hydroxyindalpine, an agonist at the putative 5-HT 1P receptor, has no activity on human recombinant monoamine receptors but accelerates distension-induced peristalsis in mouse isolated colon. Neurogastroenterology & Motility 2009;21:760-e48. [DOI: 10.1111/j.1365-2982.2009.01275.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Akiba Y, Maruta K, Narimatsu K, Said H, Kaji I, Kuri A, Iwamoto KI, Kuwahara A, Kaunitz JD. FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats. Am J Physiol Gastrointest Liver Physiol 2017;313:G117-28. [PMID: 28526687 DOI: 10.1152/ajpgi.00041.2017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Shen F, Smith JA, Chang R, Bourdet DL, Tsuruda PR, Obedencio GP, Beattie DT. 5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment. Neuropharmacology 2011;61:69-79. [DOI: 10.1016/j.neuropharm.2011.02.026] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
14 Wang SJ, Sharkey KA, McKay DM. Modulation of the immune response by helminths: a role for serotonin? Biosci Rep 2018;38:BSR20180027. [PMID: 30177522 DOI: 10.1042/BSR20180027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
15 Nacci C, Fanelli M, Potenza MA, Leo V, Montagnani M, De Salvia MA. Carbon monoxide contributes to the constipating effects of granisetron in rat colon. World J Gastroenterol 2016; 22(42): 9333-9345 [PMID: 27895421 DOI: 10.3748/wjg.v22.i42.9333] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
16 Smith TK, Park KJ, Hennig GW. Colonic migrating motor complexes, high amplitude propagating contractions, neural reflexes and the importance of neuronal and mucosal serotonin. J Neurogastroenterol Motil. 2014;20:423-446. [PMID: 25273115 DOI: 10.5056/jnm14092] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
17 Shahi PK, Choi S, Zuo DC, Yeum CH, Yoon PJ, Lee J, Kim YD, Park CG, Kim MY, Shin HR. 5-hydroxytryptamine generates tonic inward currents on pacemaker activity of interstitial cells of cajal from mouse small intestine. Korean J Physiol Pharmacol. 2011;15:129-135. [PMID: 21860590 DOI: 10.4196/kjpp.2011.15.3.129] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
18 Min YW, Rhee PL. The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D). Therap Adv Gastroenterol. 2015;8:136-142. [PMID: 25949526 DOI: 10.1177/1756283x15572580] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
19 Farjadian S, Fakhraei B, Moeini M, Nasiri M, Fattahi MR. Serotonin transporter gene polymorphisms in Southwestern Iranian patients with irritable bowel syndrome. Arab J Gastroenterol 2013;14:59-62. [PMID: 23820502 DOI: 10.1016/j.ajg.2013.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Hu D, Nakane A. Mechanisms of staphylococcal enterotoxin-induced emesis. European Journal of Pharmacology 2014;722:95-107. [DOI: 10.1016/j.ejphar.2013.08.050] [Cited by in Crossref: 76] [Cited by in F6Publishing: 52] [Article Influence: 10.9] [Reference Citation Analysis]
21 Muscatello MRA, Bruno A, Scimeca G, Pandolfo G, Zoccali RA. Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol 2014; 20(24): 7570-7586 [PMID: 24976697 DOI: 10.3748/wjg.v20.i24.7570] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
22 Martínez-Rubio C, Serrano GE, Miller MW. Localization of biogenic amines in the foregut of Aplysia californica: catecholaminergic and serotonergic innervation. J Comp Neurol 2009;514:329-42. [PMID: 19330814 DOI: 10.1002/cne.21991] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
23 Pravda J. Hydrogen peroxide and disease: towards a unified system of pathogenesis and therapeutics. Mol Med. 2020;26:41. [PMID: 32380940 DOI: 10.1186/s10020-020-00165-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Manocha M, Khan WI. Serotonin and GI Disorders: An Update on Clinical and Experimental Studies. Clin Transl Gastroenterol. 2012;3:e13. [PMID: 23238212 DOI: 10.1038/ctg.2012.8] [Cited by in Crossref: 105] [Cited by in F6Publishing: 101] [Article Influence: 11.7] [Reference Citation Analysis]
25 Kim JJ, Khan WI. 5-HT7 receptor signaling: improved therapeutic strategy in gut disorders. Front Behav Neurosci. 2014;8:396. [PMID: 25565996 DOI: 10.3389/fnbeh.2014.00396] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
26 Tzirogiannis KN, Kourentzi KT, Zyga S, Papalimneou V, Tsironi M, Grypioti AD, Protopsaltis I, Panidis D, Panoutsopoulos GI. Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy. BMC Gastroenterol 2014;14:201. [PMID: 25433672 DOI: 10.1186/s12876-014-0201-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
27 Singh H, Bala R, Kaur K. Efficacy and tolerability of levosulipride, domperidone and metoclopramide in patients with non-ulcer functional dyspepsia: a comparative analysis. J Clin Diagn Res. 2015;9:FC09-FC12. [PMID: 26023567 DOI: 10.7860/jcdr/2015/11613.5775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
28 Dicken BJ, Sergi C, Rescorla FJ, Breckler F, Sigalet D. Medical management of motility disorders in patients with intestinal failure: a focus on necrotizing enterocolitis, gastroschisis, and intestinal atresia. Journal of Pediatric Surgery 2011;46:1618-30. [DOI: 10.1016/j.jpedsurg.2011.04.002] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
29 鞠露, 孙建华, 陆高, 吴晓亮. 结肠移行性复合运动产生和传播机制的研究进展. 世界华人消化杂志 2015; 23(26): 4221-4226 [DOI: 10.11569/wcjd.v23.i26.4221] [Reference Citation Analysis]
30 Sanger GJ, Chang L, Bountra C, Houghton LA. Challenges and prospects for pharmacotherapy in functional gastrointestinal disorders. Therap Adv Gastroenterol. 2010;3:291-305. [PMID: 21180610 DOI: 10.1177/1756283X10369922] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
31 Tong W, Kamiyama Y, Ridolfi TJ, Zietlow A, Zheng J, Kosinski L, Ludwig K, Takahashi T. The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats. J Surg Res 2011;171:510-6. [PMID: 20691988 DOI: 10.1016/j.jss.2010.05.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
32 Sun H, Xu S, Yi L, Chen Y, Wu P, Cao Z, Zhou L, Jiang Y, Zhang D. Role of 5-HT1A receptor in insular cortex mediating stress - induced visceral sensory dysfunction. Neurogastroenterol Motil 2016;28:1104-13. [PMID: 26969829 DOI: 10.1111/nmo.12815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
33 Tong W, Kamiyama Y, Ridolfi TJ, Zietlow A, Zheng J, Kosinski L, Ludwig K, Takahashi T. The role of 5-HT3 and 5-HT4 receptors in the adaptive mechanism of colonic transit following the parasympathetic denervation in rats. J Surg Res. 2011;171:510-516. [PMID: 20691988 DOI: 10.1016/j.jss] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
34 Li HF, Liu JF, Zhang K, Feng Y. Expression of serotonin receptors in human lower esophageal sphincter. Exp Ther Med 2015;9:49-54. [PMID: 25452775 DOI: 10.3892/etm.2014.2050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
35 Emmanuel AV, Tack J, Quigley EM, Talley NJ. Pharmacological management of constipation. Neurogastroenterol Motil. 2009;21 Suppl 2:41-54. [PMID: 19824937 DOI: 10.1111/j.1365-2982.2009.01403.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 5.2] [Reference Citation Analysis]
36 Chang EB, Rao MC. A new role for microbiota? Dulling the thrust of serotonin and 5-HT3 signaling cascade. Am J Physiol Gastrointest Liver Physiol 2017;313:G14-5. [PMID: 28546284 DOI: 10.1152/ajpgi.00166.2017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Hedlund PB. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl) 2009;206:345-54. [PMID: 19649616 DOI: 10.1007/s00213-009-1626-0] [Cited by in Crossref: 164] [Cited by in F6Publishing: 163] [Article Influence: 13.7] [Reference Citation Analysis]
38 Broad J, Hughes F, Chin-aleong J, Sifrim D, Sanger GJ. Regionally dependent neuromuscular functions of motilin and 5-HT 4 receptors in human isolated esophageal body and gastric fundus. Neurogastroenterol Motil 2014;26:1311-22. [DOI: 10.1111/nmo.12394] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
39 Akiba Y, Inoue T, Kaji I, Higashiyama M, Narimatsu K, Iwamoto K, Watanabe M, Guth PH, Engel E, Kuwahara A, Kaunitz JD. Short-chain fatty acid sensing in rat duodenum. J Physiol 2015;593:585-99. [PMID: 25433076 DOI: 10.1113/jphysiol.2014.280792] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
40 Goldberg M, Li YP, Johanson JF, Mangel AW, Kitt M, Beattie DT, Kersey K, Daniels O. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study. Aliment Pharmacol Ther. 2010;32:1102-1112. [PMID: 21039672 DOI: 10.1111/j.1365-2036.2010.04456.x] [Cited by in Crossref: 74] [Cited by in F6Publishing: 71] [Article Influence: 6.7] [Reference Citation Analysis]
41 Nedi T, White PJ, Coupar IM, Irving HR. Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract. BMC Res Notes 2018;11:362. [PMID: 29884229 DOI: 10.1186/s13104-018-3495-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
42 Smith TK, Koh SD. A model of the enteric neural circuitry underlying the generation of rhythmic motor patterns in the colon: the role of serotonin. Am J Physiol Gastrointest Liver Physiol. 2017;312:G1-G14. [PMID: 27789457 DOI: 10.1152/ajpgi.00337.2016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
43 Jin B, Ha SE, Wei L, Singh R, Zogg H, Clemmensen B, Heredia DJ, Gould TW, Sanders KM, Ro S. Colonic Motility Is Improved by the Activation of 5-HT2B Receptors on Interstitial Cells of Cajal in Diabetic Mice. Gastroenterology 2021;161:608-622.e7. [PMID: 33895170 DOI: 10.1053/j.gastro.2021.04.040] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
44 Shekhar C, Whorwell PJ. Emerging drugs for irritable bowel syndrome. Expert Opinion on Emerging Drugs 2009;14:673-85. [DOI: 10.1517/14728210903222279] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
45 Merino B, Fernández-Díaz CM, Cózar-Castellano I, Perdomo G. Intestinal Fructose and Glucose Metabolism in Health and Disease. Nutrients 2019;12:E94. [PMID: 31905727 DOI: 10.3390/nu12010094] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
46 Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. Pharmacol Rev 2021;73:310-520. [PMID: 33370241 DOI: 10.1124/pr.118.015552] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
47 Nonogaki K, Kaji T. Pharmacological stimulation of serotonin 5-HT1B receptors enhances increases in plasma active glucagon-like peptide-1 levels induced by dipeptidyl peptidase-4 inhibition independently of feeding in mice. Diabetes Metab 2015;41:425-8. [PMID: 26234524 DOI: 10.1016/j.diabet.2015.06.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
48 Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers. J Med Chem 2012;55:9693-707. [PMID: 23102207 DOI: 10.1021/jm300943r] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
49 Lyubashina O, Sivachenko I. The 5-HT 4 receptor-mediated inhibition of visceral nociceptive neurons in the rat caudal ventrolateral medulla. Neuroscience 2017;359:277-88. [DOI: 10.1016/j.neuroscience.2017.07.039] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
50 Nay K, Smiles WJ, Kaiser J, McAloon LM, Loh K, Galic S, Oakhill JS, Gundlach AL, Scott JW. Molecular Mechanisms Underlying the Beneficial Effects of Exercise on Brain Function and Neurological Disorders. Int J Mol Sci 2021;22:4052. [PMID: 33919972 DOI: 10.3390/ijms22084052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Coupar IM, Irving HR, Manallack DT, Tan YY, Ayad F, Iulio JD, Tochon-danguy N, Iskander MN. Assessment of the pharmacological properties of 5-methoxyindole derivatives at 5-HT4 receptors. Journal of Pharmacy and Pharmacology 2012;64:1099-106. [DOI: 10.1111/j.2042-7158.2012.01500.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
52 Sanger GJ. Translating 5-HT receptor pharmacology. Neurogastroenterol Motil. 2009;21:1235-1238. [PMID: 19906028 DOI: 10.1111/j.1365-2982.2009.01425.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
53 Yu Y, Zhao F. Microbiota-gut-brain axis in autism spectrum disorder. J Genet Genomics 2021:S1673-8527(21)00206-X. [PMID: 34373221 DOI: 10.1016/j.jgg.2021.07.001] [Reference Citation Analysis]
54 Nedi T, White PJ, Coupar IM, Irving HR. Tissue dependent differences in G-protein coupled receptor kinases associated with 5-HT4 receptor desensitization in the rat gastro-intestinal tract. Biochem Pharmacol 2011;81:123-33. [PMID: 20836992 DOI: 10.1016/j.bcp.2010.09.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
55 Al-Saffar A, Takemi S, Saaed HK, Sakata I, Sakai T. Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders. Best Pract Res Clin Gastroenterol 2019;40-41:101633. [PMID: 31594654 DOI: 10.1016/j.bpg.2019.101633] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Sanger GJ. Translating 5-HT receptor pharmacology. Neurogastroenterol Motil. 2009;21:1235-1238. [PMID: 19906028 DOI: org/10.1111/j.1365-2982.2009.01425.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Bassil AK, Taylor CM, Bolton VJ, Gray KM, Brown JD, Cutler L, Summerfield SG, Bruton G, Winchester WJ, Lee K. Inhibition of colonic motility and defecation by RS-127445 suggests an involvement of the 5-HT2B receptor in rodent large bowel physiology. Br J Pharmacol. 2009;158:252-258. [PMID: 19371340 DOI: 10.1111/j.1476-5381.2009.00155.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
58 Popoff MR. Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa. Future Microbiol 2011;6:763-97. [PMID: 21797691 DOI: 10.2217/fmb.11.58] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
59 Lee MY. Clinical Relevance of Serotonin Receptor Splice Variant Distribution in Human Colon. J Neurogastroenterol Motil 2015;21:303-6. [PMID: 26130626 DOI: 10.5056/jnm15093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Hasler WL. Serotonin and the GI tract. Curr Gastroenterol Rep. 2009;11:383-391. [PMID: 19765366 DOI: 10.1007/s11894-009-0058-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
61 Charoenphandhu N, Teerapornpuntakit J, Lapmanee S, Krishnamra N, Charoenphandhu J. Duodenal calcium transporter mRNA expression in stressed male rats treated with diazepam, fluoxetine, reboxetine, or venlafaxine. Mol Cell Biochem 2012;369:87-94. [DOI: 10.1007/s11010-012-1371-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Liu BW, Li ZX, He ZG, Wang Q, Liu C, Zhang XW, Yang H, Xiang HB. Altered expression of itch‑related mediators in the lower cervical spinal cord in mouse models of two types of chronic itch. Int J Mol Med 2019;44:835-46. [PMID: 31257468 DOI: 10.3892/ijmm.2019.4253] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
63 Muscatello MR, Bruno A, Pandolfo G, Micò U, Stilo S, Scaffidi M, Consolo P, Tortora A, Pallio S, Giacobbe G. Depression, anxiety and anger in subtypes of irritable bowel syndrome patients. J Clin Psychol Med Settings. 2010;17:64-70. [PMID: 20094761 DOI: 10.1007/s10880-009-9182-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
64 Charnay Y, Léger L. Brain serotonergic circuitries. Dialogues Clin Neurosci 2010;12:471-87. [PMID: 21319493 [PMID: 21319493 DOI: 10.31887/dcns.2010.12.4/ycharnay] [Cited by in Crossref: 54] [Article Influence: 5.4] [Reference Citation Analysis]
65 Yaakob NS, Chinkwo KA, Chetty N, Coupar IM, Irving HR. Distribution of 5-HT3, 5-HT4, and 5-HT7 Receptors Along the Human Colon. J Neurogastroenterol Motil 2015;21:361-9. [PMID: 26130632 DOI: 10.5056/jnm14157] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
66 Yang L, Cai H, Tou J, Gu W, Shu X, Zhang T, Yang X, Shen Z, Jiang M. The role of the 5-hydroxytryptamine pathway in reflux-induced esophageal mucosal injury in rats. World J Surg Oncol. 2012;10:219. [PMID: 23092450 DOI: 10.1186/1477-7819-10-219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
67 Zeng F, Watson RP, Nash MS. Glial Cell–Derived Neurotrophic Factor Enhances Synaptic Communication and 5-Hydroxytryptamine 3a Receptor Expression in Enteric Neurons. Gastroenterology 2010;138:1491-501. [DOI: 10.1053/j.gastro.2009.11.048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
68 Martinucci I, Blandizzi C, de Bortoli N, Bellini M, Antonioli L, Tuccori M, Fornai M, Marchi S, Colucci R. Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders. Pharmacogenomics 2015;16:523-39. [PMID: 25916523 DOI: 10.2217/pgs.15.12] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]